Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
PaperCitations, authors & open-access status
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 407 citations, 2017 year and green oa status.
407
Citations
2017
Year
green
OA Status